デフォルト表紙
市場調査レポート
商品コード
1635539

核医学イメージング装置市場:セグメント別規模、シェア、法規制、償還、設置台数、2036年までの予測

Nuclear Imaging Equipment Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036


出版日
発行
GlobalData
ページ情報
英文
納期
即納可能 即納可能とは
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
核医学イメージング装置市場:セグメント別規模、シェア、法規制、償還、設置台数、2036年までの予測
出版日: 2024年10月31日
発行: GlobalData
ページ情報: 英文
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

核医学装置は、経口または静脈から体内に挿入される放射性物質(核医学または放射性医薬品とも呼ばれる)を利用します。これらのシステムは放射性医薬品から放出される放射線をとらえ、人体内部の構造や活動の画像を作成します。これらの画像によって医師は人体の内部を観察し、病気や怪我の原因を突き止め、正確な診断を下すことができます。

核医学イメージングとは、F-18フルオロデオキシグルコースなどの放射性トレーサーを使用して、がん、心臓、消化器、内分泌、神経疾患など、さまざまな身体機能や疾患を評価・診断する非侵襲的な医療技術です。核医学イメージング装置は、陽電子放出断層撮影(PET)システムと単一光子放出コンピュータ断層撮影(SPECT)システムに分類されます。これらのシステムの高度バージョンには、PET/CT、PET/MRI、SPECT/CT、SPECT/MRIがあり、PETとCT/MRI、SPECTとCT/MRIの両方の機能が組み込まれています。

当レポートは、世界の核医学イメージング装置市場について詳細に考察し、市場における競合情勢、SWOT分析、2015年~2036年のセグメント別年間総売上高と市場見通し、地域、国別の動向などを提供しています。

目次

現在上市されている核医学イメージング装置と競合情勢

  • 主要な業界動向の洞察
  • 核医学イメージング装置のセグメント別総市場収益と2015年~2036年の市場展望
  • 台数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

  • 核医学イメージング装置市場のSWOT分析
  • 核医学イメージング装置市場に関する競合力学の洞察と動向
  • 国別の医療制度の概要
  • 国別の償還政策
  • 国別の医療技術に関する規制の状況
目次
Product Code: GDME557MM

Nuclear Imaging Equipment Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Diagnostic Imaging therapeutic area.

Nuclear medicine equipment makes use of radioactive substances (also called as nuclear medicine or radiopharmaceuticals) that are inserted into the body orally or intravenously. These systems capture the radiations emitted by radiopharmaceuticals to create images of the structures and activities inside the human body. These images enable physicians to look inside a human body to help determine the cause of an illness or injury and provide an accurate diagnosis.

Nuclear Imaging is a non-invasive medical technique that uses radioactive tracers, such as F-18 Fluorodeoxyglucose, to evaluate and diagnose various bodily functions and diseases, including cancers, cardiac, gastrointestinal, endocrine, and neurological conditions. Nuclear Imaging Equipment's have been classified into Positron Emission Tomography (PET) Systems and Single Photon Emission Computed Tomography (SPECT) Systems. The advanced version of these systems include PET/CT, PET/MRI, SPECT/CT and SPECT/MRI, incorporating features from both PET and CT/MRI or SPECT and CT/MRI.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Nuclear Imaging Equipment and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Nuclear Imaging Equipment market revenue by segment and market outlooks from 2015-2036.
  • Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Nuclear Imaging Equipment market.
  • Competitive dynamics insights and trends provided for Nuclear Imaging Equipment market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: GE HealthCare Technologies Inc, Siemens Healthineers AG, Shanghai United Imaging Healthcare Co Ltd, Canon Medical Systems Corp and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Nuclear Imaging Equipment marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
  • Develop business strategies by understanding the trends shaping and driving Nuclear Imaging Equipment market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Nuclear Imaging Equipment market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Nuclear Imaging Equipment market from 2015-2036.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.